熱門資訊> 正文
健康催化剂2026年第一季度盈利预览
2026-05-11 05:35
- Health Catalyst (HCAT) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close.
- The consensus EPS Estimate is $0.02 (+100.0% Y/Y) and the consensus Revenue Estimate is $69.19M (-12.9% Y/Y).
- Over the last 2 years, HCAT has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 5 downward. Revenue estimates have seen 0 upward revisions and 8 downward.
More on Health Catalyst
- Health Catalyst, Inc. (HCAT) Q4 2025 Earnings Call Transcript
- Health Catalyst downgraded at Wells Fargo after Q4 results
- Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review
- Seeking Alpha’s Quant Rating on Health Catalyst
- Historical earnings data for Health Catalyst
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。